Neuropsychological assessment of HIV-seropositive haemophiliacs. 1991

A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
Department of Psychiatry, Athens University Medical School, Greece.

Neuropsychological findings from investigation of 46 HIV-seropositive asymptomatic and 14 HIV-seropositive symptomatic haemophiliacs without AIDS-related complex (ARC) or AIDS, with known duration of HIV seropositivity were compared with 29 seronegative controls. Subjects were assessed blindly using a battery of sensitive computerized neuropsychological tests. They underwent a thorough neurological examination, were assessed for mood and screened for psychopathology. Symptomatic HIV-positive haemophiliacs without ARC or AIDS showed statistically significant decreased performances compared with HIV-negatives in choice reaction, visuomotor coordination and global attentional performance (P = 0.018, 0.039 and 0.044, respectively). HIV-positive asymptomatic subjects gave lower performances than HIV-negative subjects in all tests, although these differences were not statistically significant. However, there was a statistically significant trend for these findings between seronegative, asymptomatic and symptomatic groups. Impairment was not associated with mood factors. Duration of seropositivity was found to be a more important factor than Centers for Disease Control stage in the choice reaction test (P less than 0.01). These findings indicate that mild cognitive impairment observed during the natural history of HIV infection in haemophiliacs without ARC or AIDS may be a progressive phenomenon not necessarily associated with the clinical expression of HIV infection.

UI MeSH Term Description Entries
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019964 Mood Disorders Those disorders that have a disturbance in mood as their predominant feature. Affective Disorders,Affective Disorder,Disorder, Affective,Disorder, Mood,Disorders, Affective,Disorders, Mood,Mood Disorder

Related Publications

A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
July 1996, Haemophilia : the official journal of the World Federation of Hemophilia,
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
April 1992, AIDS (London, England),
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
September 1987, Lancet (London, England),
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
April 1990, AIDS (London, England),
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
January 1997, Haemophilia : the official journal of the World Federation of Hemophilia,
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
January 1987, Clinical and laboratory haematology,
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
January 1993, Haematologia,
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
April 1991, AIDS (London, England),
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
January 1989, The Journal of neuropsychiatry and clinical neurosciences,
A Kokkevi, and A Hatzakis, and A Maillis, and J Pittadaki, and J Zalonis, and D Samartzis, and G Touloumi, and T Mandalaki, and C Stefanis
January 1991, The Journal of neuropsychiatry and clinical neurosciences,
Copied contents to your clipboard!